PROMUS Element Coronary Stent System

DEVICE4 trials

Sponsors

Boston Scientific Corporation

Conditions

AtherosclerosisCoronary Artery Disease

Phase 3

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions

CompletedNCT00823212

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-01-31End: 2014-12-31Updated: 2019-03-27

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

CompletedNCT01500434

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-02-28End: 2015-05-31Updated: 2019-03-26

Unknown Phase

Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent

CompletedNCT01285999

Boston Scientific CorporationAtherosclerosis, Coronary Artery Disease

Start: 2011-01-31End: 2014-08-31Updated: 2025-03-11

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

CompletedNCT01498692

Boston Scientific CorporationCoronary Artery Disease

Start: 2009-02-28End: 2015-05-31Updated: 2019-03-26

Related Papers

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.

2017-12-0121 citations